Kawasaki disease conjunctivitis - Causes, Treatment & When to See a Doctor

```html

What is Kawasaki disease conjunctivitis?

Kawasaki disease (KD) is an acute, self‑limited vasculitis that primarily affects children under five years of age. One of the hallmark signs of KD is a non‑purulent, bilateral conjunctival injection—commonly referred to as Kawasaki disease conjunctivitis. The redness involves both eyes, typically sparing the lids and the cornea, and appears early in the disease (often within the first few days of fever). While the eye findings themselves are not dangerous, they serve as a critical clue that helps clinicians recognise a condition that can lead to serious heart complications if untreated.

According to the Mayo Clinic, the classic diagnostic criteria for KD include fever lasting ≥5 days plus at least four of the five principal clinical features, one of which is the bilateral non‑exudative conjunctivitis.

Common Causes

Although “Kawasaki disease conjunctivitis” is specific to KD, several other conditions can cause a similar red‑eye presentation in children. Understanding these helps clinicians rule out alternatives:

• Viral conjunctivitis (adenovirus, enterovirus): watery discharge, often with a pre‑auricular lymph node.
• Bacterial conjunctivitis: purulent discharge, eyelid crusting.
• Allergic (ophthalmic) conjunctivitis: itching, seasonal pattern, eosinophils on smear.
• Uveitis (e.g., juvenile idiopathic arthritis): photophobia, deeper eye pain.
• Stevens‑Johnson syndrome / Toxic epidermal necrolysis: severe mucocutaneous involvement.
• Herpes simplex virus infection: dendritic corneal lesions, unilateral.
• Environmental irritants (smoke, chemicals): transient redness without systemic signs.
• Systemic autoimmune diseases (e.g., systemic lupus erythematosus): often accompany rash, arthritis.
• Contact lens‑related hypoxia: typically in older children/adolescents.
• Medication‑induced erythema (e.g., sulfonamides, tetracyclines): may cause photosensitivity and conjunctival redness.

In the context of Kawasaki disease, the conjunctivitis is **non‑exudative**, **bilateral**, and **does not involve the cornea**, distinguishing it from many of the above causes.

Associated Symptoms

Conjunctivitis in KD rarely occurs in isolation. The disease follows a predictable clinical pattern, and most children present with several of the following features:

• High, persistent fever: lasting ≥5 days, often >39 °C (102 °F).
• Oral mucosal changes: “strawberry tongue,” erythema of the palate, cracked lips.
• Extremity changes: erythema of the palms/soles, edema, later desquamation (peeling) around nails.
• Polymorphous rash: maculopapular, erythema multiforme‑like, or scarlatiniform.
• Cervical lymphadenopathy: typically ≥1.5 cm, unilateral.
• Cardiac involvement: coronary artery aneurysms, myocarditis, pericardial effusion (often detected later with echocardiography).
• General irritability or lethargy: especially in infants.
• Gastrointestinal symptoms: abdominal pain, vomiting, or diarrhea in up to 30 % of cases.

Because the eye findings appear early, they can prompt a timely diagnosis before cardiac complications develop.

When to See a Doctor

Prompt medical evaluation is essential. Seek pediatric care if a child has any of the following:

• Fever lasting 3 days or more with red eyes that are **bilateral and non‑purulent**.
• Any combination of the classic KD signs listed above (rash, swollen hands/feet, “strawberry” tongue, enlarged lymph node).
• Redness that does **not improve** with typical over‑the‑counter eye drops or antibiotics.
• New onset of irritability, lethargy, or reduced feeding in a febrile toddler.

Early treatment (ideally within the first 10 days of illness) reduces the risk of coronary artery aneurysms from 25 % to <5 % (American Heart Association, 2020).

Diagnosis

Diagnosing Kawasaki disease conjunctivitis is part of a broader clinical assessment for KD. No single laboratory test confirms the disease, but a combination of criteria, labs, and imaging guides the physician.

Clinical Evaluation

1. History & Physical: Detailed fever curve, presence of the five principal KD features, and review of exposure to infections or allergens.
2. Eye Examination: Ophthalmologist may confirm bilateral, non‑exudative conjunctival injection without lid involvement.

Laboratory Tests

• Complete blood count – often shows **leukocytosis** with neutrophil predominance.
• Elevated acute‑phase reactants: **CRP** >3 mg/dL or **ESR** >40 mm/hr.
• Platelet count – may rise dramatically (>450,000/µL) in the second week.
• Urinalysis – sterile pyuria is common.
• Liver enzymes (ALT/AST) and hypo‑albuminemia may be present.

Imaging

• Echocardiography: First‑line to assess coronary artery dimensions, myocardial function, and pericardial effusion.
• Electrocardiogram (ECG) – looks for arrhythmias or ischemic changes.
• In resistant cases, cardiac MRI or CT angiography may be used.

Diagnostic Criteria (American Heart Association, 2017)

Complete KD:

• Fever ≥5 days + ≥4 of the 5 principal features (including conjunctivitis).

Incomplete KD (more common in infants):

• Fever ≥5 days + 2–3 principal features plus supportive lab/imaging findings.

Treatment Options

The primary goal is to stop the inflammatory cascade and protect the coronary arteries.

Medical Therapies

• Intravenous Immunoglobulin (IVIG): 2 g/kg given as a single infusion within the first 10 days of illness. Reduces fever and inflammation in >80 % of patients.
• Aspirin: High‑dose (80–100 mg/kg/day) during the acute febrile phase, then low‑dose (3–5 mg/kg/day) for antiplatelet effect until platelet counts normalize and echo is clear (typically 6–8 weeks).
• Corticosteroids: Considered for IVIG‑resistant cases or high‑risk patients (e.g., infants <6 months). Prednisone 2 mg/kg/day tapered over 2–3 weeks.
• Biologic agents: Infliximab or anakinra may be used when fever persists after a second IVIG dose.
• Anticoagulation: Warfarin or low‑molecular‑weight heparin for large coronary aneurysms (Z‑score ≥10).

Supportive & Home Care

• Maintain adequate hydration and nutrition; small frequent meals are often better tolerated.
• Use acetaminophen for comfort if fever persists after IVIG (avoid NSAIDs until IVIG treatment is complete).
• Monitor temperature at home; record peaks and response to therapy.
• Keep the child’s environment smoke‑free and limit exposure to respiratory irritants.
• Follow‑up appointments: usually at 2 weeks, 6 weeks, and then at 6‑12 months with repeat echocardiograms.

Prevention Tips

Because the exact trigger for Kawasaki disease remains unknown, true primary prevention is not possible. However, certain actions can reduce the risk of complications and support overall health:

• Vaccinations: Keep routine immunisations up to date to prevent infections that might mimic KD.
• Hand hygiene: Frequent hand‑washing reduces spread of viral agents that can cause similar conjunctivitis.
• Prompt medical evaluation: Early recognition of prolonged fever and eye redness leads to earlier treatment.
• Awareness of family history: Siblings of a child with KD have a modestly increased risk; discuss any fever‑related concerns promptly.
• Healthy lifestyle: Balanced diet and adequate sleep support the immune system.

Emergency Warning Signs

Key Take‑aways

Kawasaki disease conjunctivitis is a classic, bilateral, non‑exudative redness of the eyes that, when seen with prolonged fever and other systemic signs, should raise suspicion for KD—a condition that can threaten a child’s heart if not treated promptly. Early recognition, IVIG therapy, and close cardiac follow‑up dramatically improve outcomes. Parents and caregivers should act quickly when fever persists beyond three days with red eyes, and they must never ignore the emergency warning signs listed above.

For further reading, consult reputable sources such as the CDC, NIH, and the American Heart Association guidelines.

```